Rabia Gurses Ozden, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Rabia Gurses Ozden, M.D.
Ocular Therapeutix, Inc reported in an 8-K filed April 18, 2024 that Rabia Gurses Ozden, M.D. resigned as Chief Medical Officer, effective May 20, 2024.
“Effective upon the commencement of Dr. Waheed's employment, Rabia Gurses Ozden, M.D., will cease to serve as the company's Chief Medical Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Ocular Therapeutix, Inc (OCUL)
SEC 8-K
2022-07-01–2024-05-20
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.